Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice

The Journal of Rheumatology
Shivani GargAliza Lipson

Abstract

The risk of developing invasive pneumococcal infection is 13 times higher in patients with systemic lupus erythematosus (SLE) in comparison with the general population. The US Centers for Disease Control and Prevention anticipates a US$7.6 million medical cost reduction by providing pneumococcal vaccination. The objective of this study was to improve the rate of combination pneumococcal vaccination (pneumococcal polysaccharide vaccine 23 + pneumococcal conjugate vaccine 13) in patients with SLE in our adult academic rheumatology practice. With the use of physician- and staff-based surveys, we analyzed the underlying barriers in providing vaccination. We then planned a multifaceted intervention including pre-visit planning, day-of-visit planning, weekly review, and monthly feedback. Our project is one of the few studies planned to improve combination pneumococcal vaccination rates in adult patients with SLE and we report an impressive improvement from 10% baseline rate to 59% vaccination rate by the end of the study period. This highlights the role of planning an intervention with an integrated workflow and the importance of sharing performance data, which leads to high compliance among team members. The significant improvement ...Continue Reading

References

Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M YeeD M Musher
Dec 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ori ElkayamJeffrey B Rubins
Aug 1, 2007·Arthritis and Rheumatism·Brent W KinderLindsey A Criswell
Mar 19, 2013·American Journal of Preventive Medicine·Kenneth J SmithRichard K Zimmerman
Mar 26, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C RockC Bergin
Jan 15, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S AlibertiF Blasi
Jul 15, 2015·The European Respiratory Journal·Marie-Josée J MangenG Ardine de Wit
Aug 26, 2015·Pediatrics·Julia G HarrisJudyann C Olson
Oct 3, 2015·Open Forum Infectious Diseases·Keyana N PennantSonali P Desai
Jan 12, 2016·Human Vaccines & Immunotherapeutics·Giuseppe MurdacaFilippo Ansaldi
Apr 19, 2016·Annals of the American Thoracic Society·Andrew C BericalJennifer D Possick

❮ Previous
Next ❯

Citations

Jun 2, 2020·Expert Review of Clinical Immunology·Megan R W Barber, Ann E Clarke
Sep 26, 2020·Frontiers in Medicine·Leonard H CalabreseVibeke Strand
May 6, 2021·Arthritis Care & Research·Candace H FeldmanKaren H Costenbader
May 3, 2021·The Journal of Rheumatology·Julia G Harris
Dec 28, 2019·Pediatrics·Vidya SivaramanMonica I Ardura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.